Tag : Multiple Myeloma

Gastroenterology

Researchers discover a way to move precision immunotherapy forward for multiple myeloma

Newsemia
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way to move precision immunotherapy forward by using genomics to inform immunotherapy...
Latest News

Exposure to 9/11 WTC dust associated with increased risk of heart disease in NYC firefighters

Newsemia
A new study of New York City firefighters has found that exposure to 9/11 World Trade Center dust is associated with a significantly increased long-term...
Latest News

New therapy found to be effective for patients with a particular type of bone marrow cancer

Newsemia
Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is...
Latest News

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Newsemia
Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva®...
Latest News

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Newsemia
Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute...
Gastroenterology

RNA and DNA sequencing platform matches broader swath of drugs to late-stage cancer patients

Newsemia
A comprehensive RNA and DNA sequencing platform benefits late-stage and drug-resistant multiple myeloma patients by determining which drugs would work best for them, according to...
Latest News

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Newsemia
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy